Edgewise Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Edgewise Therapeutics, Inc. has filed 418 SEC EDGAR filings since 26 Sep 2019

SEC filing history

Showing 351-375 of 418 matching filings.

Per page
25
Current page
15
4

PRIMARY DOCUMENT

Filing date
03 Nov 2021
Reporting date
01 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. FORM 8-K

Filing date
28 Oct 2021
Reporting date
28 Oct 2021
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Oct 2021
Reporting date
14 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Oct 2021
Reporting date
11 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Oct 2021
Reporting date
06 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Oct 2021
Reporting date
01 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Sep 2021
Reporting date
28 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Sep 2021
Reporting date
23 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. FORM 8-K

Filing date
09 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92424

SCHEDULE 13G

Filing date
12 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92424

SC 13G filing

Filing date
18 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 May 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
04 May 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92424

SCHEDULE 13D

Filing date
03 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92424

SCHEDULE 13D

Filing date
08 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92424

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .